Xilio Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Xilio Therapeutics, Inc.
CIK #0001840233
EDGAR Form CIK 2011 - 2024
10-K [0001840233]
10-Q [0001840233]
3 [0001840233]
4 [0001840233]
8-K [0001840233]
D [0001840233]
SC 13D [0001840233]
SC 13G [0001840233]
Form 13D/13G Filer Form 13D/13G Subject Filed
GKCC LLC Xilio Therapeutics Inc [2024-09-27]
Gilead Sciences Inc Xilio Therapeutics Inc [2024-04-05]
Rock Springs Capital Management LP Xilio Therapeutics Inc [2024-02-14]
MRL Ventures Fund LLC Xilio Therapeutics Inc [2023-04-10]
Octagon Capital Advisors LP Xilio Therapeutics Inc [2023-01-25]
Takeda Pharmaceutical Co Ltd Xilio Therapeutics Inc [2022-01-14]
Bain Capital Life Sciences Fund II LP Xilio Therapeutics Inc [2021-11-05]
Atlas Venture Fund Xi LP Xilio Therapeutics Inc [2021-11-05]
RA Capital Management LP Xilio Therapeutics Inc [2021-11-05]
Rivervest Venture Fund IV LP Xilio Therapeutics Inc [2021-11-05]
View All
Form 3/4/5 Subject 2011 - 2024
Brennan Kevin M.
Xilio Therapeutics, Inc.
GKCC LLC
Chudnovsky Yekaterina
Frankenfield Christopher James
Ross Robert W
Rossi Christina
Clancy Paul J
Curran Daniel J.
Shannon James Samuel
View All
Terms | Privacy | Guide
tony@aum13f.com